<DOC>
	<DOCNO>NCT00820664</DOCNO>
	<brief_summary>The purpose study examine effect two different dose level estrogen placebo healthy postmenopausal woman measure change hormone level examine change uterine lining ( endometrium ) .</brief_summary>
	<brief_title>A Clinical Study Evaluate Effects Estrogen Healthy Postmenopausal Women</brief_title>
	<detailed_description />
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<criteria>Patient healthy postmenopausal woman less equal 65 year age onset menopause less equal 10 year prior prestudy visit 1 Patient uterus history uterine bleeding past 3 month Patient previous endometrial biopsy within last 4 week Patient normal mammogram within last 11 month Patient normal papsmear within past 3 year prior screen Patient normal transvaginal ultrasound endometrium Patient willing avoid strenuous physical activity strenuous unaccustomed weight lifting , run , bicycling , etc duration study Patient agree consume grapefruit product begin approximately 2 week prior first dose study drug throughout study Patient agree limit daily consumption alcohol . During study , daily alcohol consumption 2 glass Patient agrees limit daily consumption caffeine . During study , daily caffeine consumption exceed 3 cup coffee Patient nonsmoker Patient mentally legally incapacitated Patient history first degree relative breast endometrial cancer Patient history multiple and/or severe allergy prescription nonprescription drug food Patient use type estrogen progesterone preparation unless follow appropriate washout period Patient surgery , donate approximately 500 mL blood participate another investigational study within last 4 week Patient history deep vein thromboses , coronary artery disease , heart attack stroke Patient current user illegal drug Patient history hypersensitivity estrogen product Patient unable refrain use anticoagulant</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>